RECRUITING

Evaluation of Repeated, In-Clinic, Self-Imaging by DME Patients Using the Notal Vision Home OCT

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Evaluation of Repeated, In-Clinic, Self-Imaging by DME Patients Using the Notal Vision Home OCT The purpose of this study is to collect data on the NVHO device at up to three sites.

Official Title

Evaluation of Repeated, In-Clinic, Self-Imaging by DME Patients Using the Notal Vision

Quick Facts

Study Start:2022-11-07
Study Completion:2023-07-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05745116

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Ability to speak, read and understand English.
  2. * Ability to agree, understand and sign the informed consent form.
  3. * Eighteen (18) years of age or older at the time of Informed Consent.
  4. * Subjects diagnosed with DR (Diabetic Retinopathy) in at least one eye, with or without DME
  5. * Best corrected Visual Acuity of 20/320 (6/96) or better in eyes participating at the study.
  1. * Subjects with dilated pupils.
  2. * Subjects with other retinal disease requiring steroidal or anti-VEGF injections

Contacts and Locations

Study Contact

Elizabeth Leicht
CONTACT
830-285-2508
elizabeth@dynamictrialconsultants.com
Theresa Landry
CONTACT
theresa.landry@notalvision.com

Study Locations (Sites)

Elman Retina Group, PA
Baltimore, Maryland, 21237
United States
The Retina Group of Washington
Fairfax, Virginia, 22031
United States
Wagner Kapoor Research Institute
Norfolk, Virginia, 23502
United States

Collaborators and Investigators

Sponsor: Notal Vision Inc.

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-11-07
Study Completion Date2023-07-31

Study Record Updates

Study Start Date2022-11-07
Study Completion Date2023-07-31

Terms related to this study

Additional Relevant MeSH Terms

  • Diabetic Macular Edema